Ask a Care Navigator about patient support resources. Call 1-844-4S-WITHME (1-844-479-4846), Monday through Friday, from 8:00 AM to 8:00 PM ET.

SPRAVATO®
Patient Stories Real people. Really inspiring stories.
Watch Nicole’s Story
Nicole: There were days where I would just break down crying in my bathroom because I just couldn’t do it. I couldn’t get up. I couldn’t take a shower. I couldn’t physically do anything.
SUPER: Nicole’s Story
SUPER:
Nicole
Age 23 | Missouri
SUPER: Nicole, 23, is a real patient with treatment-resistant depression and has been compensated for her time by Janssen Pharmaceuticals, Inc.
Nicole: It was bad. I was kind of cruel towards my mom at times. And there were points where she would just cry because of things I said or things I did. And I didn’t understand that I was being cruel. I didn’t understand that at all. I just lashed out. I ended up going to college. I stayed for about two months. Semester started in August. I dropped out and was home before Halloween. I would sleep 18 to 20 hours a day. I wouldn’t shower for three months. It was crazy. I was getting worse over time. I was having a lot more negative thoughts about myself. And so all these negative thoughts about how I just failed—I failed as a person, I failed myself, I failed my mom, I failed my teachers.
It kind of spirals, to the point where I really hated myself. And I remember thinking, “But I just want to fall asleep and never wake up again.” I walked in to my current psychiatrist with a legitimate page and a half full of medicines that I’d already tried that didn’t work. We found out that I have treatment-resistant depression. At some point, my psychiatrist talked to me about this medical trial study for SPRAVATO®. It really does help with treatment-resistant depression.
SUPER: Individual results may vary.
Speaker/SUPER: SPRAVATO® is the first FDA-approved nasal spray, taken along with an oral antidepressant, for adults with treatment-resistant depression. It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®. SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic) and it is not for use in children. SPRAVATO® can cause serious side effects including sleepiness, fainting, dizziness, spinning sensation, anxiety or feeling disconnected from yourself, your thoughts, feelings or things around you. Your healthcare provider will monitor you for at least two hours after taking SPRAVATO®. Please see additional Important Safety Information later in this video.
Nicole: Sometimes with depression, not only do you feel it emotionally, it feels like a weight. I was just so light. That was something so new to me.
SUPER: In a clinical study of adults with treatment-resistant depression, those who took SPRAVATO® and an oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received a placebo plus an oral antidepressant.
Nicole: When I was truly in my throes of depression, I would start every day off at like a negative six versus a zero. After I started taking SPRAVATO®, I’m starting off the day waking up neutral, which is the best. My mom is my best friend. She is the best. And she has sacrificed her entire life for me and she’s so good. And she is. I’m actually just finishing up my first semester. Eventually, I want to transfer out of my community college. I’m learning so much stuff and I’m growing as a person. So it’s awesome.
I’m 23 now and I’m almost 24, and I never thought I would live to be 24. I just have so many opportunities. It’s awesome.
Speaker/SUPER:
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
-
Sedation and dissociation. SPRAVATO® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation).
- Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out.
- Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO®. Your healthcare provider will decide when you are ready to leave the healthcare setting.
-
Abuse and misuse. There is a risk for abuse and physical and psychological dependence with SPRAVATO® treatment. Your healthcare provider should check you for signs of abuse and dependence before and during treatment with SPRAVATO®.
- Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.
- Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
- SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS). Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program.
-
Increased risk of suicidal thoughts and actions. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed.
SPRAVATO® is not for use in children
- Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a higher risk of having suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions.
-
How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
- Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions.
- Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings.
- Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
-
Tell your healthcare provider right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
- suicide attempts
- thoughts about suicide or dying
- worsening depression
- other unusual changes in behavior or mood
Do not take SPRAVATO® if you:
- have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs)
- have an abnormal connection between your veins and arteries (arteriovenous malformation)
- have a history of bleeding in the brain
- are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®.
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
-
have heart or brain problems, including:
- high blood pressure (hypertension)
- slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting
- history of heart attack
- history of stroke
- heart valve disease or heart failure
- history of brain injury or any condition where there is increased pressure in the brain
- have liver problems
- have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true).
-
are pregnant or plan to become pregnant. SPRAVATO® may harm your baby. You should not take SPRAVATO® if you are pregnant.
- Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO®.
- If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO®.
- There is a pregnancy registry for women who are exposed to SPRAVATO® during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO® and their baby. If you become pregnant during treatment with SPRAVATO®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
- are breastfeeding or plan to breastfeed. You should not breastfeed during treatment with SPRAVATO®.
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
- You will take SPRAVATO® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Your healthcare provider will show you how to use the SPRAVATO® nasal spray device.
- Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it.
- Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to.
- During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting.
- You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®.
- If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule.
- Some people taking SPRAVATO® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®.
- If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO®.
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
- See “What is the most important information I should know about SPRAVATO®?”
- Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
- Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
- Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® when used along with an antidepressant taken by mouth include:
- feeling disconnected from yourself, your thoughts, feelings and things around you
- dizziness
- nausea
- feeling sleepy
- spinning sensation
- decreased feeling of sensitivity (numbness)
- feeling anxious
- lack of energy
- increased blood pressure
- vomiting
- feeling drunk
- feeling very happy or excited
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® at SPRAVATO.com and discuss any questions you may have with your healthcare provider.
SUPER:
cp-79822v3
SUPER:
© Janssen Pharmaceuticals, Inc. 2021. All rights reserved. 08/21 cp-72100v5
“I no longer start off each day sad and about to cry. With SPRAVATO®, I’m starting off at a place like neutral, which is, like, the best.”
Nicole P., St. Peters, Missouri
Nicole, 23*, is a real patient with treatment-resistant depression and has been compensated for her time and testimonial by Janssen Pharmaceuticals, Inc.
*Testimonial filmed in 2018.
“SPRAVATO® has made a difference in my depression symptoms. I’m back in college full-time now and growing as a person. I keep up with my SPRAVATO® treatments and my therapy. Lately, I’ve been sharing my story with others because I want people who are struggling to know that I was in their shoes and things can get better.”

How Far She’s Come
One year after sharing her story, Nicole has written a personal update at The Mighty! Read how she is continuing her education, reflecting on her experiences and sharing what she wishes people understood about treatment-resistant depression.
There’s an increased risk of suicidal thoughts and behavior with SPRAVATO®. Call your healthcare provider right away if you have new or sudden changes in mood, behavior, thoughts or feelings, or if you develop suicidal thoughts or behavior.
Watch Allison’s Caregiver Story
Allison: All of my effort, all of my attention went to him and finding the right treatment. To have tried everything and to know he’s not getting better, that was very difficult.
SUPER:
A Caregiver’s Story
About Treatment-Resistant Depression
SUPER:
Allison
Pikeville, Kentucky
SUPER: Allison is a real caregiver for her adult son with treatment-resistant depression and is an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Allison: He was just a very sensitive child. My son would not ever want a balloon because he knew it wouldn’t last. So if he lost it, he would start immediately crying. And high school, that’s when we really started seeing the depression. He started sleeping more, wrecking his room, not wanting to go to school. I actually had a truancy officer come and visit me. So you’re talking about a straight-A student that got a scholarship from the University of Kentucky that was now in danger of failing his senior year. So we got with this psychologist and talked to her and she recommended that he might need to start on some sort of medication.
He tried around seven or eight and different combinations of oral medications, after like two, three months, they would just fail. Nothing seemed to work. He was getting ready to move away to go to school, and I was going to have to say goodbye to him and watch him leave the nest when I knew he was really not well. I was a worried mama. I spent a lot of time on the road going back and forth to make sure he was okay. I would go and check on him and, you know, his room would be a mess, and he would be a mess, and he would be sleeping all the time. When a person has treatment-resistant depression, they really aren’t taking care of themselves. And it’s not that they don’t want to, it’s just they’re in this cycle and they don’t know how to get out of it. I spent a lot of time on the phone, you know, talking to a psychologist, talking to the psychiatrist about what we were going to do next because he wasn’t getting any better. In fact, he was getting worse.
I had four other kids at home, and I wasn’t able to give them the attention, love, whatever they needed, which hurts me because, you know, I do love my children very much. So, a lot of those drives were spent in tears. You feel hopeless and helpless. It’s your baby. No matter how old they are, that’s still your baby. After he had been in school for a little while, I got the call that every mother dreads: he had tried to commit suicide. And, you know, it’s one of those things that—it’s surreal, you just can’t imagine your life without your child. But treatment-resistant depression is a disease, just like diabetes or anything else. I mean, you just have to keep going, because it’s your child’s life. Luckily SPRAVATO® came out when it did.
Speaker/SUPER: SPRAVATO® is the first FDA-approved nasal spray, taken along with an oral antidepressant, for adults with treatment-resistant depression. It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®. SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic) and it is not for use in children. SPRAVATO® can cause serious side effects including sleepiness, fainting, dizziness, spinning sensation, anxiety or feeling disconnected from yourself, your thoughts, feelings or things around you. Your healthcare provider will monitor you for at least two hours after taking SPRAVATO®. Please see additional Important Safety Information later in this video.
Allison: So, after a few weeks, his symptoms started to improve and his hygiene got better. He started calling me on the phone more, he became interested in gardening and cooking.
SUPER: In a clinical study of adults with treatment-resistant depression, those who took SPRAVATO® and an oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received a placebo plus an oral antidepressant.
Individual results may vary.
Allison: He composts, he has pumpkins, he has spinach, he has blueberries. Anytime that he gets off from work, he’s out working in his garden. In addition to the SPRAVATO®, he’s taken an oral antidepressant. My son is 22 now. He’s doing so much better. He’s working in a restaurant. He aspires to go to chef school soon. And I was able to get my mind off of just him. I’m there for my kids more; I’m there for my husband.
The misconception is you should be able to pull yourself up by the bootstraps and just be able to get yourself out of it, and that’s simply not true. You have to have a team and you have to have the right medications to carry on. When somebody has treatment-resistant depression, it’s easy for them to lose hope, so you have to be that hope for them. I think the future is very bright for my son. I think he’s going to be a renowned chef. I mean, that’s my hopes for him, but most of all, I want him to be happy. There is hope out there. I’ve gotten my son back.
Speaker/SUPER:
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
-
Sedation and dissociation. SPRAVATO® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation).
- Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out.
- Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO®. Your healthcare provider will decide when you are ready to leave the healthcare setting.
-
Abuse and misuse. There is a risk for abuse and physical and psychological dependence with SPRAVATO® treatment. Your healthcare provider should check you for signs of abuse and dependence before and during treatment with SPRAVATO®.
- Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.
- Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
- SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS). Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO® is only available through a restricted program called the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® REMS Program. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program.
-
Increased risk of suicidal thoughts and actions. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed.
SPRAVATO® is not for use in children
- Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a higher risk of having suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions.
-
How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
- Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions.
- Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings.
- Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
-
Tell your healthcare provider right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
- suicide attempts
- thoughts about suicide or dying
- worsening depression
- other unusual changes in behavior or mood
Do not take SPRAVATO® if you:
- have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs)
- have an abnormal connection between your veins and arteries (arteriovenous malformation)
- have a history of bleeding in the brain
- are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®.
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
-
have heart or brain problems, including:
- high blood pressure (hypertension)
- slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting
- history of heart attack
- history of stroke
- heart valve disease or heart failure
- history of brain injury or any condition where there is increased pressure in the brain
- have liver problems
- have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true).
-
are pregnant or plan to become pregnant. SPRAVATO® may harm your baby. You should not take SPRAVATO® if you are pregnant.
- Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO®.
- If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO®.
- There is a pregnancy registry for women who are exposed to SPRAVATO® during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO® and their baby. If you become pregnant during treatment with SPRAVATO®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
- are breastfeeding or plan to breastfeed. You should not breastfeed during treatment with SPRAVATO®.
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
- You will take SPRAVATO® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Your healthcare provider will show you how to use the SPRAVATO® nasal spray device.
- Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it.
- Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to.
- During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting.
- You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®.
- If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule.
- Some people taking SPRAVATO® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®.
- If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO®.
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
- See “What is the most important information I should know about SPRAVATO®?”
- Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
- Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
- Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® when used along with an antidepressant taken by mouth include:
- feeling disconnected from yourself, your thoughts, feelings and things around you
- dizziness
- nausea
- feeling sleepy
- spinning sensation
- decreased feeling of sensitivity (numbness)
- feeling anxious
- lack of energy
- increased blood pressure
- vomiting
- feeling drunk
- feeling very happy or excited
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® at SPRAVATO.com and discuss any questions you may have with your healthcare provider.
SUPER:
cp-79822v3
SUPER:
© Janssen Pharmaceuticals, Inc. 2021. All rights reserved. 09/21 cp-191060v2
“My son is 22* now and he’s doing so much better with SPRAVATO®. He aspires to go to chef school. I think the future is very bright for him now.”
Allison F., Pikesville, Kentucky
Caregiver for son with treatment-resistant depression
Allison is a real caregiver for her adult son with treatment-resistant depression. She is an employee of Janssen Pharmaceuticals Companies of Johnson & Johnson.
*Testimonial filmed in 2021.
“When someone has treatment-resistant depression like my son, they aren’t taking care of themselves. Its not that they don’t want to, it’s just they’re in this cycle and they don’t know how to get out of it. But with the right medication and therapy, there may be hope.”
There’s an increased risk of suicidal thoughts and behavior with SPRAVATO®. Call your healthcare provider right away if you have new or sudden changes in mood, behavior, thoughts or feelings, or if you develop suicidal thoughts or behavior.
These are individual testimonials and individual results may vary. When discussing treatment with SPRAVATO®, be sure to tell your healthcare provider about your complete medical history, including if you have a history of abusing prescription or street drugs or a problem with alcohol. Tell your healthcare provider if you are pregnant or are planning to become pregnant. Your healthcare provider will discuss the possible side effects of SPRAVATO® so that you can decide together if SPRAVATO® may be right for you.
More Stories:

Nicole
SPRAVATO® helped Nicole’s treatment-resistant depression. Now, she’s resuming her education and sharing her story.

Allison
Allison’s son tried many oral antidepressants without relief. Now, because of SPRAVATO®, Allison’s son is starting to feel like himself again.
These are individual testimonials and individual results may vary. When discussing treatment with SPRAVATO®, be sure to tell your healthcare provider about your complete medical history, including if you have a history of abusing prescription or street drugs or a problem with alcohol. Tell your healthcare provider if you are pregnant or are planning to become pregnant. Your healthcare provider will discuss the possible side effects of SPRAVATO® so that you can decide together if SPRAVATO® may be right for you.




Your Story Matters, Share It
Has SPRAVATO® made a difference with your treatment-resistant depression? Share your story with the SHARE Network.
Help is available 24/7. If you’re struggling with suicidal thoughts, call the National Suicide Prevention Lifeline: 1-800-273-8255.
Help is available 24/7. If you’re struggling with suicidal thoughts, call the National Suicide Prevention Lifeline: 1-800-273-8255.
English 1-800-273-8255
Español 1-888-628-9454
The National Suicide Prevention Lifeline is a federally funded network of crisis centers committed to suicide prevention.
English 1-800-273-8255
Español 1-888-628-9454
The National Suicide Prevention Lifeline is a federally funded network of crisis centers committed to suicide prevention.


Next:
Coverage & Cost Support
Information you may need to help you get started and stay on track.